Available Until 10/25/2025

Pharmacist Provided Reproductive Health Services Post Roe v. Wade Reversal

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists – Clinical Leadership Section Advisory Group 

ACPE Activity Number: 0204-0000-22-163-H01-P
Release Date: Oct 25, 2022 
Expiration Date: Oct 25, 2025 
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEU)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

This activity will provide pharmacists with information about navigating the recent U.S. Supreme Court ruling on Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade. The presentation will clarify concepts, describe therapeutic options, provide resources, and outline the public health impact of this decision on reproductive health services nationwide. 


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity was planned to meet the needs of clinical pharmacists seeking to learn more about the therapeutics of medication abortion as well as other reproductive health service considerations for patients.  

After completing this activity, the learner should be able to… 

1. Discuss the potential impact on patient care of the Supreme Court decision to overturn Roe v. Wade. 

2. Define the pharmacist’s role in medication abortion and reproductive health services. 

3. List resources critical to advocacy and provision of patient care in reproductive health services. 

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Veronica Vernon, PharmD, BCPS, BCACP, NCMP
Assistant Professor
Butler University College of Pharmacy and Health Sciences
Indianapolis, IN

Ashley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCP
Clinical Professor
Purdue University College of Pharmacy
West Lafayette, IN

Rena Gosser, PharmD, BCPS

Clinical Ambulatory Pharmacy Manager
Harborview Medical Center
Clinical Assistant Professor
University of Washington School of Pharmacy
Seattle, WA

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.